MCR - Desc-hbr

De-escalating Antiplatelet Therapy to Assess Platelet Reactivity and Outcomes in High Bleeding Risk Patients With Recent ACS (DESC-HBR)

PHASE

III

NCT Number

NCT05903976

DEFINITION

Pharmacological

SPONSOR

Azienda Ospedaliera Universitaria Policlinico "G. Martino"